PEDIATRICS Vol. 97 No. 1 January 1996, pp. 126-127
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Good, W. V.
Right arrow Articles by Crain, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Good, W. V.
Right arrow Articles by Crain, L. S.

Esotropia in a Child Treated With a Scopolamine Patch for Drooling

William V. Good MD1 and Lucy S. Crain MD2

1 Department of Ophthalmology and Abrahamson Pediatric Eye Institute, Cincinnati Children's Hospital, University of Cincinnati College of Medicine
2 Departments of Pediatrics and Family and Community Medicine, University of California, San Francisco

Drooling in children who have neurodevelopmental disabilities can pose a substantial problem. Recent studies have indicated that, because of its anticholinergic effect, the use of a scopolamine patch may help eliminate drooling.1,2 The ease of administration of the patch, coupled with its very low side-effect Profile, adds to its desirability. However, we want to alert care givers to a problem we attribute to the scopolamine patch. Esotropia developed in one of our patients when scopolamine transdermal patching was done. The esotropia resolved shortly after cessation of patching.

CASE REPORT

This 4-year-old boy has spastic quadriplegia, a significant developmental delay, a well-controlled seizure disorder, and microcephaly secondary to a neonatal cerebrovascular hemorrhage associated with a protein C deficiency clotting disorder.

Submitted on November 28, 1994
Accepted on February 15, 1995